Caoimhe (@CNAT86) header
Caoimhe (@CNAT86) profile picture

Caoimhe

@CNAT86

Science, food & business • Lonrú Consulting • Founder of @SculleryMade

 Ireland
linkedin.com/profile/view?id=182991079
Joined July 2009
  • Tweets709
  • Following386
  • Followers122
35Media
Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)
This is not just copilot. This is M&S copilot 😅
Rowland Manthorpe (@rowlsmanthorpe) profile pictureRowland Manthorpe
@rowlsmanthorpeMar 26
If you want to know how corporate uptake of AI is going in the UK, M&S just sent out a press release boasting about their purchase of 11,000 licences for... Copilot
Image from Rowland Manthorpe (@rowlsmanthorpe)
59
UK’s MHRA just unlocked bedside manufacturing for #CART & gene-edited cells. How do FDA FRAME, Japan’s ASRM & China’s dual-track stack up; and what does it mean for toolmakers racing to equip hospital micro-factories? Dive into the latest #LonrúLens 👉 lonruconsulting.com/blog-1-1…
Lonrú Consulting | Life-Science Strategy and Digital Infrastructure

Lonrú Consulting | Life-Science Strategy and Digital Infrastructure

Life-science strategy, governed data, and practical digital infrastructure for complex therapies and the organisations that support them.

lonruconsulting.com
54
An historic moment in molecular medicine. An historic moment for SCD and BT patients. 🙌
CRISPR Therapeutics (@CRISPRTX) profile pictureCRISPR Therapeutics@CRISPRTX16 Nov 2023
The UK Medicines and Healthcare products Regulatory Agency approves the CRISPR/Cas9 gene-edited treatment for #SickleCellDisease & #BetaThalassemia in Great Britain. This is a historic milestone arising out of our collaboration with Vertex. Learn more: crisprtx.com
Image from CRISPR Therapeutics (@CRISPRTX)
1
115
What an amazing experience ringing the @Nasdaq closing bell! Thank you to our employees and partners for helping make this incredible milestone happen!
Image from MaxCyte, Inc. (@MaxCyte_info)
Image from MaxCyte, Inc. (@MaxCyte_info)
2
5
2
18
MaxCyte is excited to take part in today’s @Nasdaq closing bell ceremony! At 3:50pm ET head over to Nasdaq’s livestream to view our leadership team ring the closing bell: ow.ly/Cgvo50Gh14d.
Image from MaxCyte, Inc. (@MaxCyte_info)
2
4
2
19
💙 @OvarianCancerUK doing brilliant work to try to address this. Please read @DrNadiaChaudhri thread for her experience with OvCar. ⬇️
Dr. Nadia Chaudhri (@DrNadiaChaudhri) profile pictureDr. Nadia Chaudhri@DrNadiaChaudhri13 Sep 2021
Replying to @DrNadiaChaudhri
But the bottom line is that ovarian cancer research is underfunded. We also need more awareness of symptoms because early detection improves prognosis dramatically.
1
Really looking forward to this!
MaxCyte, Inc. (@MaxCyte_info) profile pictureMaxCyte, Inc.@MaxCyte_info26 Mar 2021
Join us for a webinar Apr 7 that will showcase the development of a genome-wide #CRISPR screen in primary #Tcells to identify drug targets for immune-mediated inflammatory diseases (#IMIDs). Preliminary data obtained from a mini screen will be discussed. ow.ly/RTDr50E5BfZ.
Image from MaxCyte, Inc. (@MaxCyte_info)
2
Starting a PhD soon? Download this easy to use thesis planner (free). You can map out the major phases of your #PhD. Then bring it along to a meeting with your supervisor and discuss if realistic. buff.ly/2NMM78T #PhDchat #ECRchat #postdoc #research #PhDforum
Image from Hugh Kearns (@ithinkwellHugh)
Image from Hugh Kearns (@ithinkwellHugh)
19
147
14
538
Join us for a webinar Apr 7 that will showcase the development of a genome-wide #CRISPR screen in primary #Tcells to identify drug targets for immune-mediated inflammatory diseases (#IMIDs). Preliminary data obtained from a mini screen will be discussed. ow.ly/RTDr50E5BfZ
Image from MaxCyte, Inc. (@MaxCyte_info)
2
6
Congratulations to our partner, @SangamoTx, on the Orphan Designation for BIVV003 for the treatment of #sicklecelldisease: ow.ly/ytDJ50E5dJJ via @GENbio. @sanofi @EMA_News #celltherapy #SCD
Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy

Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy

An ex vivo gene-edited cell therapy for sickle cell disease (SCD) being developed by Sangamo Therapeutics and Sanofi has generated positive early Phase I/II results in three patients—data that...

genengnews.com
8
2
29
Love to watch these murmurations!
James Crombie (@INPHOjames) profile pictureJames Crombie@INPHOjames4 Mar 2021
What an amazing few months it has been chasing the murmurations around Lough Ennell looking for the shot with @hogg82, our patience eventually paid off. Thanks so much to the @IrishTimes for the wonderful usage today
Image from James Crombie (@INPHOjames)
Image from James Crombie (@INPHOjames)
Caoimhe retweeted
ASGCT (@ASGCTherapy) profile picture
ASGCT
@ASGCTherapy3 Mar 2021
#Sicklecell disease occurs when a person inherits a faulty beta-globin gene. Learn more about #genetherapy and #geneediting approaches to treat #SCD: bit.ly/39cHSMZ #bleedingdisordersawarenessmonth
Image from ASGCT (@ASGCTherapy)
7
9
March is #OvarianCancerAwarenessMonth and @OvarianCancerUK are doing some wonderful work to raise awareness, improve diagnosis and treatment and are working towards a goal of 0 deaths from OvCar in the future 💙💙💙
Ovarian Cancer Action (@OvarianCancerUK) profile pictureOvarian Cancer Action@OvarianCancerUK1 Mar 2021
It’s Ovarian Cancer Awareness Month, and we’re highlighting the inequalities thousands of women with ovarian cancer are facing. We want to make sure all women have access to the same level of care. Find out more 👇

We recognize #RareDiseaseDay as a way to raise awareness about rare conditions, celebrate our research, treatment, and cures progress, and show our support for the need for continued research. @RareDiseases #RareIsMany #ShowYourStripes
Image from MaxCyte, Inc. (@MaxCyte_info)
3
7
Is í Aimee Mackin ó Ard Mhaca imreoir sinsir na bliana @TG4TV Comhghairdeas leat @aimee_mackin agus le @ArmaghLGFA @AIGIreland @ladiesfootball #ProperFan #EffortisEqual
Image from Spórt TG4 (@SportTG4)
3
9
3
174
MaxCyte's Doug Doerfler, President & CEO, and Amanda Murphy, CFO, will present a corporate overview at the Cowen Annual Health Care Conference on March 1 from 1:20 – 1:50 p.m. ET. ow.ly/EGvt50DKHQF
Image from MaxCyte, Inc. (@MaxCyte_info)
2
8
Mark your calendar for March 10 to learn about MaxCyte’s easy, scalable and cGMP-compliant #electroporation platform for #CellTherapy & #ProteinProduction applications at @MyABRF's Annual Meeting: abrf.org/abrf-events. #MyExpertPlatform #ABRF2021 #SilverSponsor
Image from MaxCyte, Inc. (@MaxCyte_info)
3
5
🆕 Calling all data-focussed biotech start-ups. The @SteBioCat DATA accelerator programme can provide you with training and mentoring, helping develop the ideas and skills to move to the next phase. Open for applications now bit.ly/2Zm7Hpy #SBCAccelerator #Biotech
Image from BioIndustry Association (BIA) (@BIA_UK)
1
2
“Single step engineering, multiplexed, elegant, scalable technologies that will allow pharma-like manufacturing of cell therapies are key to expanding the market.” Marco Alessandrini #antionbiosciences @CAR_TCell @MaxCyte_info
2
5
More complex cell therapies demand an equally gentle and robust technology to enable multiple engineering steps - that’s what MaxCyte’s ExPERT platforms enable 🦋
MaxCyte, Inc. (@MaxCyte_info) profile pictureMaxCyte, Inc.@MaxCyte_info9 Feb 2021
A great video snippet of the work our partner, @AllogeneTx, is doing with their AlloCAR T™ approach. #Innovation #CellTherapy #GeneEditing
4
Load more